These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1700066)

  • 1. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.
    Meyer H; Masuho Y; Mach M
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2443-50. PubMed ID: 1700066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies.
    Meyer H; Sundqvist VA; Pereira L; Mach M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2375-83. PubMed ID: 1383409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.
    Utz U; Britt W; Vugler L; Mach M
    J Virol; 1989 May; 63(5):1995-2001. PubMed ID: 2467992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
    Ohlin M; Sundqvist VA; Mach M; Wahren B; Borrebaeck CA
    J Virol; 1993 Feb; 67(2):703-10. PubMed ID: 7678304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals.
    Ayata M; Sugano T; Murayama T; Sakamuro D; Takegami T; Matsumoto Y; Furukawa T
    J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93.
    Liu YN; Curtsinger J; Donahue PR; Klaus A; Optiz G; Cooper J; Karr RW; Bach FH; Gehrz RC
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2207-14. PubMed ID: 7691989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
    Speckner A; Glykofrydes D; Ohlin M; Mach M
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
    Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.
    Urban M; Klein M; Britt WJ; Hassfurther E; Mach M
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1537-47. PubMed ID: 8757997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.
    Urban M; Britt W; Mach M
    J Virol; 1992 Mar; 66(3):1303-11. PubMed ID: 1371164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new look at a poorly immunogenic neutralization epitope on cytomegalovirus glycoprotein B. Is there cause for antigen redesign?
    Ohlin M
    Mol Immunol; 2014 Aug; 60(2):95-102. PubMed ID: 24802891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus.
    Darlington J; Super M; Patel K; Grundy JE; Griffiths PD; Emery VC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1985-9. PubMed ID: 1714945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.
    Wagner B; Kropff B; Kalbacher H; Britt W; Sundqvist VA; Ostberg L; Mach M
    J Virol; 1992 Sep; 66(9):5290-7. PubMed ID: 1323695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the major glycoprotein gene of human cytomegalovirus.
    Mach M; Utz U; Fleckenstein B
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1461-7. PubMed ID: 2873201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.
    Britt WJ; Auger D
    J Virol; 1986 Apr; 58(1):185-91. PubMed ID: 3005648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
    Tarar MR; Emery VC; Harrison TJ
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):183-92. PubMed ID: 9116635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.